These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 26675887)
61. Dopamine D1 and D3 Receptors Modulate Heroin-Induced Cognitive Impairment through Opponent Actions in Mice. Zhu Y; Wang Y; Lai J; Wei S; Zhang H; Yan P; Li Y; Qiao X; Yin F Int J Neuropsychopharmacol; 2017 Mar; 20(3):257-268. PubMed ID: 27815417 [TBL] [Abstract][Full Text] [Related]
62. Effects of local infusions of apomorphine on the extracellular citrulline level in the striatum: Involvement of D1 and D2 dopamine receptors. Savel'ev SA Neurosci Behav Physiol; 2006 Nov; 36(9):1009-13. PubMed ID: 17024340 [TBL] [Abstract][Full Text] [Related]
63. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice. Collins GT; Truccone A; Haji-Abdi F; Newman AH; Grundt P; Rice KC; Husbands SM; Greedy BM; Enguehard-Gueiffier C; Gueiffier A; Chen J; Wang S; Katz JL; Grandy DK; Sunahara RK; Woods JH J Pharmacol Exp Ther; 2009 Apr; 329(1):210-7. PubMed ID: 19136638 [TBL] [Abstract][Full Text] [Related]
64. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709 [TBL] [Abstract][Full Text] [Related]
65. A dopamine D1 agonist elevates self-stimulation thresholds: comparison to other dopamine-selective drugs. Baldo BA; Jain K; Veraldi L; Koob GF; Markou A Pharmacol Biochem Behav; 1999 Apr; 62(4):659-72. PubMed ID: 10208371 [TBL] [Abstract][Full Text] [Related]
66. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44. Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754 [TBL] [Abstract][Full Text] [Related]
67. The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists. McCreary AC; Handley SL Eur J Pharmacol; 1999 Mar; 369(1):1-9. PubMed ID: 10204674 [TBL] [Abstract][Full Text] [Related]
68. Involvement of the presynaptic dopamine D2 receptor in the depression of spinal reflex by apomorphine. Gajendiran M; Seth P; Ganguly DK Neuroreport; 1996 Jan; 7(2):513-6. PubMed ID: 8730818 [TBL] [Abstract][Full Text] [Related]
69. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells. Li Z; Yu C; Han Y; Ren H; Shi W; Fu C; He D; Huang L; Yang C; Wang X; Zhou L; Asico LD; Zeng C; Jose PA Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2761-8. PubMed ID: 18441198 [TBL] [Abstract][Full Text] [Related]
70. Effect of dopamine on NaCl transport in the medullary thick ascending limb of the rat. Grider J; Kilpatrick E; Ott C; Jackson B Eur J Pharmacol; 1998 Jan; 342(2-3):281-4. PubMed ID: 9548397 [TBL] [Abstract][Full Text] [Related]
71. Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open-field behavior. Salmi P; Ahlenius S Neuroreport; 2000 Apr; 11(6):1269-72. PubMed ID: 10817605 [TBL] [Abstract][Full Text] [Related]
72. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors. Salmi P; Ahlenius S Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951 [TBL] [Abstract][Full Text] [Related]
73. Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431. Shiosaki K; Asin KE; Britton DR; Giardina WJ; Bednarz L; Mahan L; Mikusa J; Nikkel A; Wismer C Eur J Pharmacol; 1996 Dec; 317(2-3):183-90. PubMed ID: 8997599 [TBL] [Abstract][Full Text] [Related]
74. Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958. Cory-Slechta DA; McCoy L; Richfield EK J Neurochem; 1997 May; 68(5):2012-23. PubMed ID: 9109527 [TBL] [Abstract][Full Text] [Related]
75. The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat. Schechter MD Psychopharmacology (Berl); 1995 May; 119(1):79-84. PubMed ID: 7675953 [TBL] [Abstract][Full Text] [Related]
76. Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets. Nakazawa S; Murai T; Miyauchi M; Kotani M; Ikeda K Psychopharmacology (Berl); 2015 Sep; 232(17):3287-95. PubMed ID: 26041337 [TBL] [Abstract][Full Text] [Related]
77. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits. Carnicella S; Drui G; Boulet S; Carcenac C; Favier M; Duran T; Savasta M Transl Psychiatry; 2014 Jun; 4(6):e401. PubMed ID: 24937095 [TBL] [Abstract][Full Text] [Related]
78. Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907. Kleven MS; Koek W Eur J Pharmacol; 1997 Feb; 321(1):1-4. PubMed ID: 9083778 [TBL] [Abstract][Full Text] [Related]
79. Facilitation of preparatory behavior in an artificial prey paradigm by D1-subfamily dopamine receptor activation. Tinsley MR; Rebec GV; Timberlake W Behav Brain Res; 2000 Sep; 114(1-2):23-30. PubMed ID: 10996043 [TBL] [Abstract][Full Text] [Related]
80. Differential sensitivity to acute administration of Ritalin, apomorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior. Rhodes JS; Garland T Psychopharmacology (Berl); 2003 May; 167(3):242-50. PubMed ID: 12669177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]